目的:借鉴美国的临床药师培养模式,完善我国药学专业型人才培养方法,培养出能指导临床合理用药的临床药师。方法:以美国南加州大学药学院(USC school of pharmacy)的Pharm D教育为例,简单介绍美国如何培养Pharm D的临床实践能力,并与我...目的:借鉴美国的临床药师培养模式,完善我国药学专业型人才培养方法,培养出能指导临床合理用药的临床药师。方法:以美国南加州大学药学院(USC school of pharmacy)的Pharm D教育为例,简单介绍美国如何培养Pharm D的临床实践能力,并与我国现行的临床药师培养模式进行对比。结果:我国药学院课程设置不够合理,本科毕业生缺乏临床思维,无法胜任临床药师一职。结论:从课程、学制、毕业后教育等方面入手,改良传统药学教育模式,培养具备丰富临床实践经验的药学人才。展开更多
以美国内布拉斯加医学中心(University of Nebraska Medical Center,UNMC)岗位胜任力为导向培养Pharm.D.为例,介绍了其灵活多样的课堂教学方法、丰富充实的实践课程、注重人文素质培养的教育理念。临床中药学作为一门新兴的医药交叉学科...以美国内布拉斯加医学中心(University of Nebraska Medical Center,UNMC)岗位胜任力为导向培养Pharm.D.为例,介绍了其灵活多样的课堂教学方法、丰富充实的实践课程、注重人文素质培养的教育理念。临床中药学作为一门新兴的医药交叉学科,对人才的培养存在一些不足,建议结合美国Pharm.D.培养的先进经验,构建符合学科特色的临床中药学人才培养体系,培养优秀的临床中药学人才,为中医药事业的持续发展做出贡献。展开更多
In order to carry out the comprehensive reform of the professional master’s degree training mode of clinical pharmacy, we carried out interviews among 91 persons on the professional master’s degree of clinical pharm...In order to carry out the comprehensive reform of the professional master’s degree training mode of clinical pharmacy, we carried out interviews among 91 persons on the professional master’s degree of clinical pharmacy in Peking University School of Pharmaceutical Sciences and collected extensive feedback. We preliminaries explore the mode of Doctor of Pharmacy（Pharm. D.） Education, laying the foundation for Doctor’s education of professional clinical pharmacy in China. We conducted investigations and interviews among 91 clinical pharmacists and students of Peking University School of Pharmaceutical Sciences on the training of professional master’s degree and Pharm. D. education mode, which includes 67 postgraduates and 24 clinical pharmacists. Respondents put forward the problems of training mode and corresponding suggestions and opinions from different aspects during the investigation and interview. The results mainly divide into four aspects： curriculum setting, clinical practice, assessme nt system and teaching resources. Respondents put forward effective feedback on the above four aspects, which are beneficial to the comprehensive reform of the training mode of professional master degree in clinical pharmacy and preliminary exploration of Pharm. D. Education in China.展开更多
Ilexonin A is a compound isolated from the root of Ilex pubescens,a traditional Chinese medicine.Ilexonin A has been shown to play a neuroprotective role by regulating the activation of astrocytes and microglia in the...Ilexonin A is a compound isolated from the root of Ilex pubescens,a traditional Chinese medicine.Ilexonin A has been shown to play a neuroprotective role by regulating the activation of astrocytes and microglia in the peri-infarct area after ischemia.However,the effects of ilexonin A on astrocytes and microglia in the infarct-free region of the hippocampal CA1 region remain unclear.Focal cerebral ischemia models were established by 2-hour occlusion of the middle cerebral artery in rats.Ilexonin A(20,40 or 80 mg/kg)was administered immediately after ischemia/reperfusion.The astrocyte marker glial fibrillary acidic protein,microglia marker Iba-1,neural stem cell marker nestin and inflammation markers were detected by immunohistochemistry and western blot assay.Expression levels of tumor necrosis factor-αand interleukin 1βwere determined by enzyme linked immunosorbent assay in the hippocampal CA1 tissue.Astrocytes were activated immediately in progressively increasing numbers from 1,3,to 7 days post-ischemia/reperfusion.The number of activated astrocytes further increased in the hippocampal CA1 region after treatment with ilexonin A.Microglial cells remained quiescent after ischemia/reperfusion,but became activated after treatment with ilexonin A.Ilexonin A enhanced nestin expression and reduced the expression of tumor necrosis factor-αand interleukin 1βin the hippocampus post-ischemia/reperfusion.The results of the present study suggest that ilexonin A has a neuroprotective effect in the hippocampus after ischemia/reperfusion,probably through regulating astrocytes and microglia activation,promoting neuronal stem cell proliferation and reducing the levels of pro-inflammatory factors.This study was approved by the Animal Ethics Committee of the Fujian Medical University Union Hospital,China.展开更多
文摘目的:借鉴美国的临床药师培养模式,完善我国药学专业型人才培养方法,培养出能指导临床合理用药的临床药师。方法:以美国南加州大学药学院(USC school of pharmacy)的Pharm D教育为例,简单介绍美国如何培养Pharm D的临床实践能力,并与我国现行的临床药师培养模式进行对比。结果:我国药学院课程设置不够合理,本科毕业生缺乏临床思维,无法胜任临床药师一职。结论:从课程、学制、毕业后教育等方面入手,改良传统药学教育模式,培养具备丰富临床实践经验的药学人才。
文摘以美国内布拉斯加医学中心(University of Nebraska Medical Center,UNMC)岗位胜任力为导向培养Pharm.D.为例,介绍了其灵活多样的课堂教学方法、丰富充实的实践课程、注重人文素质培养的教育理念。临床中药学作为一门新兴的医药交叉学科,对人才的培养存在一些不足,建议结合美国Pharm.D.培养的先进经验,构建符合学科特色的临床中药学人才培养体系,培养优秀的临床中药学人才,为中医药事业的持续发展做出贡献。
文摘In order to carry out the comprehensive reform of the professional master’s degree training mode of clinical pharmacy, we carried out interviews among 91 persons on the professional master’s degree of clinical pharmacy in Peking University School of Pharmaceutical Sciences and collected extensive feedback. We preliminaries explore the mode of Doctor of Pharmacy（Pharm. D.） Education, laying the foundation for Doctor’s education of professional clinical pharmacy in China. We conducted investigations and interviews among 91 clinical pharmacists and students of Peking University School of Pharmaceutical Sciences on the training of professional master’s degree and Pharm. D. education mode, which includes 67 postgraduates and 24 clinical pharmacists. Respondents put forward the problems of training mode and corresponding suggestions and opinions from different aspects during the investigation and interview. The results mainly divide into four aspects： curriculum setting, clinical practice, assessme nt system and teaching resources. Respondents put forward effective feedback on the above four aspects, which are beneficial to the comprehensive reform of the training mode of professional master degree in clinical pharmacy and preliminary exploration of Pharm. D. Education in China.
基金supported by the Natural Science Foundation of Fujian Province of China,No.2014J01327the Program for New Century Excellent Talents in Colleges and Universities of Fujian Province of China,No.NCETFJ-0704the Professorial Academic Development Foundation of Fujian Medical University of China,No.JS09014(all to GYZ)
文摘Ilexonin A is a compound isolated from the root of Ilex pubescens,a traditional Chinese medicine.Ilexonin A has been shown to play a neuroprotective role by regulating the activation of astrocytes and microglia in the peri-infarct area after ischemia.However,the effects of ilexonin A on astrocytes and microglia in the infarct-free region of the hippocampal CA1 region remain unclear.Focal cerebral ischemia models were established by 2-hour occlusion of the middle cerebral artery in rats.Ilexonin A(20,40 or 80 mg/kg)was administered immediately after ischemia/reperfusion.The astrocyte marker glial fibrillary acidic protein,microglia marker Iba-1,neural stem cell marker nestin and inflammation markers were detected by immunohistochemistry and western blot assay.Expression levels of tumor necrosis factor-αand interleukin 1βwere determined by enzyme linked immunosorbent assay in the hippocampal CA1 tissue.Astrocytes were activated immediately in progressively increasing numbers from 1,3,to 7 days post-ischemia/reperfusion.The number of activated astrocytes further increased in the hippocampal CA1 region after treatment with ilexonin A.Microglial cells remained quiescent after ischemia/reperfusion,but became activated after treatment with ilexonin A.Ilexonin A enhanced nestin expression and reduced the expression of tumor necrosis factor-αand interleukin 1βin the hippocampus post-ischemia/reperfusion.The results of the present study suggest that ilexonin A has a neuroprotective effect in the hippocampus after ischemia/reperfusion,probably through regulating astrocytes and microglia activation,promoting neuronal stem cell proliferation and reducing the levels of pro-inflammatory factors.This study was approved by the Animal Ethics Committee of the Fujian Medical University Union Hospital,China.
